DT.BIOTECH INNOV.AG O.N./ DE000A0Z25L1 /
| 2024-05-22 4:41:47 PM | Chg. -0.150 | Volume | Bid5:43:38 PM | Ask5:43:38 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.200EUR | -11.11% | 2 Turnover: 2.400 |
1.000Bid Size: 1,000 | 1.530Ask Size: 2 | 1.14 mill.EUR | 0.00% | - |
Assets
| 2012 HGB in mill. EUR |
2013 HGB in mill. EUR |
2014 HGB in mill. EUR |
2015 HGB in mill. EUR |
2016 HGB in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Intangible Assets | - | - | - | - | - | ||||||
| Long-Term Investments | 1 | 1 | 1 | 1.3000 | 2 | ||||||
| Fixed Assets | 1 | 1 | 1 | 1.3000 | 2 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | .2000 | .1500 | .5000 | 1.5000 | .2000 | ||||||
| Current Assets | .2000 | .3000 | .5500 | 1.6000 | .2000 | ||||||
| Total Assets | 1.2000 | 1.3000 | 1.5000 | 2.9000 | 2.3000 | ||||||
Liabilities
| 2012 HGB in mill. EUR |
2013 HGB in mill. EUR |
2014 HGB in mill. EUR |
2015 HGB in mill. EUR |
2016 HGB in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | - | - | - | - | - | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | .3000 | .1000 | .1000 | .5000 | .0900 | ||||||
| Share Capital | .8000 | .8000 | .8940 | .9440 | .9440 | ||||||
| Total Equity | 1 | 1.2000 | 1.4000 | 2.5000 | 2.2000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 1.2000 | 1.3000 | 1.5000 | 2.9000 | 2.3000 | ||||||
Income Statement
| 2012 HGB in mill. EUR |
2013 HGB in mill. EUR |
2014 HGB in mill. EUR |
2015 HGB in mill. EUR |
2016 HGB in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 0.0000 | 0.0000 | .1000 | .2000 | .2000 | ||||||
| Depreciation (total) | - | - | - | .0100 | - | ||||||
| Operating Result | -.1000 | -.0800 | 0.0000 | -.6000 | -.2000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -.1000 | -.0800 | -.1500 | -.6000 | -.2000 | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -.1000 | -.0850 | -.1500 | -.6000 | -.3000 | ||||||
Per Share
Cash Flow
| 2012 HGB in mill. EUR |
2013 HGB in mill. EUR |
2014 HGB in mill. EUR |
2015 HGB in mill. EUR |
2016 HGB in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | - | - | - | -.5000 | -.2000 | ||||||
| Cash Flow from Investing Activities | - | - | - | -.3000 | -.8000 | ||||||
| Cash Flow from Financing | - | - | - | 1.6000 | 0.0000 | ||||||
| Decrease / Increase in Cash | - | - | - | .7000 | -1 | ||||||
| Employees | - | - | - | - | 5 | ||||||
